PFAS Accountability Act of 2025
Sponsored By: Senator Sen. Gillibrand, Kirsten E. [D-NY]
Introduced
Summary
Creates a federal cause of action and medical monitoring remedy for people exposed to PFAS. It would let individuals significantly exposed to per- and polyfluoroalkyl substances sue manufacturers involved in making those PFAS and seek court-ordered medical exams and related relief.
Show full summary
- Families and individuals: People with significant exposure could obtain court-ordered medical monitoring if they meet four conditions, including significant exposure and an increased risk of a PFAS-related disease.
- Manufacturers and suppliers: Liability reaches makers involved in PFAS-creating processes, explicitly including telomer, fluorosurfactant, and toll manufacturers. A presumption of significant exposure applies if PFAS were released into areas where exposure occurred for at least one year or if testing shows PFAS or metabolites in bodies; class actions can use representative testing or exposure patterns to establish that presumption.
- Courts and research: If toxicological data are insufficient, courts may lower the usual standards for scientific proof and may order new epidemiological or toxicological studies. The bill expresses that courts should encourage reliable, independent PFAS health research.
- State and legal landscape: The measure preserves state-law claims and remedies and does not create the exclusive legal remedy.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
New federal PFAS lawsuit rights
If enacted, the bill would let you sue in federal court if you were significantly exposed to PFAS or reasonably suspect exposure. You could sue any person involved in making the PFAS who should have foreseen human exposure. The bill would define PFAS as perfluoroalkyl or polyfluoroalkyl chemicals with at least one fully fluorinated carbon atom.
Court-ordered medical monitoring access
If enacted, courts could order medical monitoring for people or classes with significant PFAS exposure who face higher disease risk. To get monitoring, courts would look for increased risk, a need for extra periodic exams, and that tests can detect a PFAS-related disease. Courts could lower proof standards or order studies when scientific data are lacking. The bill would not stop state-law PFAS claims.
Easier exposure proof — but testing rules
If enacted, courts could assume you had significant PFAS exposure if you were in places with PFAS releases for at least one cumulative year or tests show PFAS in your body. A defendant could pay for independent testing to try to disprove that presumption. If parties cannot agree on a lab, a court would pick one.
Free Policy Watch
You just read the policy. Now see what it costs you.
Pick a topic. PRIA runs your household against live legislation and sends you a free personalized readout.
Pick a topic to get started
Sponsors & CoSponsors
Sponsor
Sen. Gillibrand, Kirsten E. [D-NY]
NY • D
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in